oral letrozole Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88
    Novartis oral letrozole
    Clinical response of DCIS after <t>letrozole</t> treatment. ( A – C ) Tumor size of DCIS patients treated with letrozole evaluated by ultrasonography (US). The median value of the greatest dimension was illustrated by a horizontal line in the box pot, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line. The statistical analyses were performed using a Wilcoxon signed rank test ( A , B ), and a Mann–Whitney U -test ( C ). P -value
    Oral Letrozole, supplied by Novartis, used in various techniques. Bioz Stars score: 88/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oral letrozole/product/Novartis
    Average 88 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    oral letrozole - by Bioz Stars, 2020-08
    88/100 stars
      Buy from Supplier

    88
    Sun Pharma oral letrozole
    Clinical response of DCIS after <t>letrozole</t> treatment. ( A – C ) Tumor size of DCIS patients treated with letrozole evaluated by ultrasonography (US). The median value of the greatest dimension was illustrated by a horizontal line in the box pot, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line. The statistical analyses were performed using a Wilcoxon signed rank test ( A , B ), and a Mann–Whitney U -test ( C ). P -value
    Oral Letrozole, supplied by Sun Pharma, used in various techniques. Bioz Stars score: 88/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oral letrozole/product/Sun Pharma
    Average 88 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    oral letrozole - by Bioz Stars, 2020-08
    88/100 stars
      Buy from Supplier

    Image Search Results


    Clinical response of DCIS after letrozole treatment. ( A – C ) Tumor size of DCIS patients treated with letrozole evaluated by ultrasonography (US). The median value of the greatest dimension was illustrated by a horizontal line in the box pot, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line. The statistical analyses were performed using a Wilcoxon signed rank test ( A , B ), and a Mann–Whitney U -test ( C ). P -value

    Journal: British Journal of Cancer

    Article Title: Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

    doi: 10.1038/bjc.2013.284

    Figure Lengend Snippet: Clinical response of DCIS after letrozole treatment. ( A – C ) Tumor size of DCIS patients treated with letrozole evaluated by ultrasonography (US). The median value of the greatest dimension was illustrated by a horizontal line in the box pot, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line. The statistical analyses were performed using a Wilcoxon signed rank test ( A , B ), and a Mann–Whitney U -test ( C ). P -value

    Article Snippet: They received oral letrozole (Femara; Novartis Pharma (Tokyo, Japan)), 2.5 mg daily for 3–27 weeks before breast-conserving surgery.

    Techniques: MANN-WHITNEY

    Morphological features of DCIS at baseline ( A ) and corresponding post-treatment ( B , C ) (Case 1). Increased periductal fibrosis ( B ) and infiltration of foam cells ( C ) were observed after the letrozole treatment as shown by arrows. Hematoxylin and eosin (HE) staining. Bar=100 μm, respectively. A full colour version of this figure is available at the British Journal of Cancer journal online.

    Journal: British Journal of Cancer

    Article Title: Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

    doi: 10.1038/bjc.2013.284

    Figure Lengend Snippet: Morphological features of DCIS at baseline ( A ) and corresponding post-treatment ( B , C ) (Case 1). Increased periductal fibrosis ( B ) and infiltration of foam cells ( C ) were observed after the letrozole treatment as shown by arrows. Hematoxylin and eosin (HE) staining. Bar=100 μm, respectively. A full colour version of this figure is available at the British Journal of Cancer journal online.

    Article Snippet: They received oral letrozole (Femara; Novartis Pharma (Tokyo, Japan)), 2.5 mg daily for 3–27 weeks before breast-conserving surgery.

    Techniques: Staining

    Tissue concentration of estrone ( A ), estradiol ( B ) and androstenedione ( C ) in DCIS with or without letrozole treatment using LC-MS/MS analysis. A horizontal line in the box pot illustrated the median value, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line ( n =2). The statistical analyses were performed using a Mann–Whitney U -test. P -values

    Journal: British Journal of Cancer

    Article Title: Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

    doi: 10.1038/bjc.2013.284

    Figure Lengend Snippet: Tissue concentration of estrone ( A ), estradiol ( B ) and androstenedione ( C ) in DCIS with or without letrozole treatment using LC-MS/MS analysis. A horizontal line in the box pot illustrated the median value, and grey box denotes the 75th (upper margin) and 25th percentiles of the values (lower margin), respectively. The upper and lower bars indicate the 90th and 10th percentiles, respectively. Each value was shown in an open circle, and the paired values from the same patient were connected in a line ( n =2). The statistical analyses were performed using a Mann–Whitney U -test. P -values

    Article Snippet: They received oral letrozole (Femara; Novartis Pharma (Tokyo, Japan)), 2.5 mg daily for 3–27 weeks before breast-conserving surgery.

    Techniques: Concentration Assay, Liquid Chromatography with Mass Spectroscopy, Mass Spectrometry, MANN-WHITNEY